Authors


Pamela B. Landsman-Blumberg, DrPH, MPH

Latest:

Adherence and Persistence of Bimatoprost in Prior Latanoprost Users

A new ophthalmic formulation of bimatoprost was found to improve adherence and persistence compared with the original formulation of bimatoprost.


David Bai

Latest:

Link Between Rheumatoid Arthritis and Huntington Disease Discovered

By mapping out the epigenomic landscape of rheumatoid arthritis, scientists hope to gain insight on disease origins as well as new cell signaling pathways.


Bryce Platt, PharmD

Latest:

Bipolar Disorder: Opportunity for Pharmacists to Improve Adherence and Health Outcomes

As highly accessible health care professionals, pharmacists have the opportunity to improve medication adherence and health outcomes of patients with bipolar disorder.


Emily A. Vail, MD, MSc

Latest:

Clinical Use of Generic Injectable Drugs in Hospitalized Patients

In acute-patient-care settings, injectable drugs are used ubiquitously. Injectables offer several advantages over other administration routes, including precise and adjustable dosing, predictable bioavailability, and fast onset of action.


Jason C. Gallagher, PharmD, FCCP, FIDSA, BCPS

Latest:

Infectious Diseases: New Opportunities for Pharmacists

Society of Infectious Diseases Pharmacists just celebrated its 25th anniversary and has seen sustained growth in its membership, influence, and responsibility since its inception.




Claudio Faria, PharmD, MPH

Latest:

5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors

Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.


Heidi C. Waters, MBA

Latest:

Rheumatoid Arthritis and Joint Replacement: Impact of Biologics

Since the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.


Jessica L. Kerr, PharmD, CDE

Latest:

Sodium-Glucose Co-Transporter-2 Inhibitors: An Update on the Evidence for Treatment of Type 2 Diabetes

Sodium-glucose co-transporter-2 inhibitors are a class of antihyperglycemic agents that can be used to improve glycemic control in the treatment of type 2 diabetes.


Aimee Simone, Assistant Editor

Latest:

Job Loss Fears May Raise Asthma Risk

Those who fear they will lose their jobs have an increased risk of developing incident asthma.


Chiou-Fang Chiou, PhD

Latest:

Claims Data Analysis of Dosing and Cost of TNF Antagonist

Higher drug costs may be attributable to either high initial doses or a dose increase.


Ali Din

Latest:

The Cloud Is Casting Its Welcome Shadow on the Pharmaceutical Industry

Pharmacies may be able to achieve significant savings and operational efficiencies with the cloud.


Bethany Rettberg, NPC

Latest:

Discuss Adverse Effects of Vaping With Patients

They may mistakenly believe that e-cigarettes are safe and wonder why they cause a cough.


Kristen Bunnell, PharmD, BCCCP

Latest:

New Antimicrobials Expand Treatment Options

Eravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections


Erin N. Deja, PharmD Candidate

Latest:

Death With Dignity: A Right or a Crime?

Five states—Oregon, Washington, Vermont, Colorado, and California—and the District of Columbia now have Death With Dignity acts.



Vaishali D. Patel, PharmD

Latest:

Claims Data Analysis of Dosing and Cost of TNF Antagonist

Higher drug costs may be attributable to either high initial doses or a dose increase.


Jason M. Broderick

Latest:

Cabozantinib Granted FDA Approval for Advanced HCC

The FDA has approved cabozantinib (Cabometyx, Exelixis) as a treatment for patients with hepatocellular carcinoma (HCC) who previously received sorafenib (Nexavar, Bayer).


Louis F. McIntyre, MD

Latest:

Impact of Hyaluronic Acid Injections on Pain Management Medications Utilization

This study assessed the impact of initiating hyaluronic acid injections on pain management pharmacotherapies utilization patterns in patients with knee osteoarthritis.


Roger A. Santos, PharmD

Latest:

National Panel Updates Its Asthma Guideline

The National Asthma Education and Prevention Program's Expert Panel has issued revised guidelines for treating asthma in children and adults.


Kyle Skiermont, PharmD

Latest:

Indecision Is Not an Option: Understanding the Range of Business Models for Health-System Specialty Pharmacy

When planning for a specialty pharmacy within a health system, 3 business models should be considered: build, partner, and outsource.


Sandra Goldstein, RN

Latest:

Cost Outcomes of Diabetes Education in a Specialized Community Pharmacy

Diabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.


Georgia Burnett, Creative Design Technician, QS/1

Latest:

Pharmacies Expand Through Deliveries and Providing Vaccinations

Providing vaccinations to patients and offering delivery services are excellent ways for pharmacies to grow their business.


Jennifer Powers, PharmD, Senior Manager, Patient Care

Latest:

The Role of the Pharmacist as Part of a Multidisciplinary Cancer Care Team

The high-level monitoring required for self-managing patients with cancer becomes a challenge when patients are seen less frequently by their provider.


Stacey Ruf, PhD

Latest:

Prescription Utilization by Multiple Sclerosis Patients in the United States

Future costs of MS therapy are likely to increase due to new add-on therapy combined with double-digit growth in utilization for existing drugs.


Kent C. Hunter, PharmD

Latest:

The Value-Based Model: Health Management Worth Exploring

The author broadly discusses the concept of value-based insurance design and provides examples of three corporations that have implemented this benefit model.



Kirk McKay

Latest:

Leading by Examples of Value over Volume

At the American Pharmacists Association 2017 meeting, an inspiring and practical session titled “Leading by Example” showed how pharmacists can leverage their value to establish health care team partnerships (eg, with health systems and physician practices) and implement programs to win pharmacy “champions,” improve patient outcomes, and reduce health care costs.